EdgeRock Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
EdgeRock Capital's ELV Position: Q1 2024 in Review
EdgeRock Capital sold out of Elevance Health (ELV) in Q1 2024, closing a stake of 293 shares — an estimated $145K sold.
EdgeRock Capital first reported a position in ELV in Q3 2022 and held it in 2 quarters. The position peaked at $145K in Q4 2023. 1,666 funds tracked by Wall St. Rank hold ELV as of Q1 2024.
- EdgeRock Capital reported no remaining Elevance Health position as of Q1 2024 after selling out during the quarter.
- EdgeRock Capital sold 293 Elevance Health shares in Q1 2024, an estimated $145K.
- EdgeRock Capital first reported a position in Elevance Health in Q3 2022 and held it in 2 quarters.
- EdgeRock Capital's Elevance Health position peaked at $145K in Q4 2023.
- 1,666 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.
Based on EdgeRock Capital's 13F filing for Q1 2024, filed 15 May 2024.